MacroGenics Inc Sustainability Reports
MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative antibody-based therapeutics to modulate the human immune response for the treatment of cancer.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493001KJQUA83L8MH79
FIGI: BBG001S9C8R7
7 reports from 2013 to 2024
